Publications by authors named "George Volakakis"
Article Synopsis
- This study investigates the outcomes of using the Endurant II/IIs device for elective endovascular aneurysm repair (EVAR) in patients with abdominal aortic aneurysms (AAAs) from 2008 to 2024.
- The primary outcomes measured included technical success, mortality, and complications within 30 days, with secondary outcomes focused on long-term survival and endoleak incidents.
- Results indicated a high technical success rate (99.7%), low 30-day mortality (0.6%), and promising long-term outcomes, with less than 50% of patients needing reintervention after 7 years.
Endovascular aortic aneurysm repair (EVAR) represents a valid treatment modality for ruptured abdominal aortic aneurysms (rAAAs). This study aimed to present rAAA outcomes treated by EVAR using the Endurant endograft. A single-center retrospective analysis of consecutive patients treated with standard EVAR (sEVAR) or parallel graft (PG)-EVAR for infra- or juxta/para-renal rAAA using the Endurant endograft (1 January 2008-31 December 2023) was undertaken.
View Article and Find Full Text PDFThere has been a debate about whether maximum diameter can be solely used to assess the natural history of abdominal aortic aneurysm. The aim of the present review is to collect all the available evidence on the role of abdominal aortic aneurysm (AAA) volume in the natural history of AAAs, including small untreated AAAs and AAAs treated by EVAR. The current literature appears to reinforce the role of volume as a supplementary measure for evaluating the natural history of AAA, in both intact AAAs and after EVAR.
View Article and Find Full Text PDF